Associate Physician Director, Illinois CancerCare. Physician Director of Clinical Research and Pharmacy Services, Illinois CancerCare
Oncology
Dr. Sachdev P. Thomas, MD
|
|
Give Review
Sachdev Thomas is an expert in the field of Oncology. He graduated from Chicago Medical School at Rosalind Franklin University. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Sachdev P. Thomas, MD is a published doctor and has 9 publications published. The lastest was: 'A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321.
- NCCTG N0821 (Alliance): A Phase II First-Line Study of Pemetrexed, Carboplatin, and Bevacizumab in Elderly Patients with Advanced Nonsquamous Non-Small-Cell Lung Cance...
- Phase II Study Of The Oral MEK Inhibitor Selumetinib In Advanced Acute Myeloid Leukemia (AML): A University Of Chicago Phase II Consortium Trial.
- A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung Cancer: Eastern Cooperative Oncology Group Study 1503.
- Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary ...
- Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal Cancer: phase II results from th...
- A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell Cancer.
- Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Loyola University -
Chicago Medical School at Rosalind Franklin University -
St. John's Medical College
Hospital
-
OSF Saint Elizabeth Medical Center
Drug Facts
| NPI NUMBER | 1245239367 | |
| NPPES Provider LastName | THOMAS | |
| NPPES Provider FirstName | SACHDEV | |
| NPPES Provider ZIPCode | 616157822 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1435.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 175.0 | |
| Percent Opioid Claims | 12.2 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245239367 |
| Last Name Of The Provider | THOMAS |
| First Name Of The Provider | SACHDEV |
| View All |
Similar Doctors
|
|
Dr. Pankaj Kumar, MD |
|
|
Dr. Sumita Bhatta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James B. Gerstner, MD |